Article Information
History
- July 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patrick Aouad1,
- Yueyun Zhang1,
- Céline Stibolt1,
- Sendurai A. Mani2,
- George Sflomos1 and
- Cathrin Brisken1,3,*
- 1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
- 2Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas 77030
- 3The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
- ↵*To whom correspondence should be addressed: Cathrin Brisken, MD, PhD ISREC - Swiss Institute for Experimental Cancer Research École Polytechnique Fédérale de Lausanne (EPFL), SV2.832 Station 19, CH-1015 Lausanne, Switzerland. E-mail: cathrin.brisken{at}epfl.ch
Posted July 26, 2021.
Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
